2014-01-02 16:38:28 UTC

GastroSlides Focus on Cirrhosis and Portal Hypertension

Jan. 9, 2014

This month's images focus on the causes, diagnosis and management of cirrhosis and its most common complication — portal hypertension.

GastroSlides offers a comprehensive, growing collection of images on major GI and liver disease topics. Developed by internationally renowned authors, the images are a valuable resource to help you create high-quality presentations that explain the complex concepts and processes of digestive diseases.

This month's images focus on the causes, diagnosis and management of cirrhosis and its most common complication — portal hypertension — and are separated into the following sections:

  • Part I: Cirrhosis: Definition, Natural History and Diagnosis
  • Part II: Pathophysiology and Types of Portal Hypertension
  • Part III: Hyperdynamic Circulatory State
  • Part IV: Varices and Variceal Hemorrhage
  • Part V: Ascites
  • Part VI: Spontaneous Bacterial Peritonitis
  • Part VII: Hepatorenal Syndrome
  • Part VIII: Hepatic Encephalopathy
  • Part IX: Hepatopulmonary Syndrome
  • Part X: Portopulmonary Hypertension
  • Part XI: Liver Transplant

Order these slides individually as you need them or purchase a one-year subscription and have access to the entire GastroSlides library of more than 4,000 images. Preview and order slides.

Special offer: get your free download of the GastroSlides unit on liver cancer (revised).

GastroSlides is a continuing education resource directed by the AGA Institute Education and Training Committee.

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Oct. 1, 2017

Among HCV-infected patients treated with DAAs, SVR is associated with a considerable reduction in the risk of HCC; however, the risk for HCC remained high in patients with cirrhosis at the time of SVR.